Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (71-80 of 345) with videos related to

Pageof 35
Sort By:
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
Arthritis Research & Therapy|May 30, 2019
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practiceUlf Lindström, Tor Olofsson, Sara Wedrén, et al.
Arthritis Care & Research|March 17, 2025
Juvenile Idiopathic Arthritis, Earnings, and Work Loss: A Nationwide Matched Cohort StudyHeather Miller, Martin Neovius, Erik Sundberg, et al.
Archives of Internal Medicine|July 16, 2003
Causes of death in patients with celiac disease in a population-based Swedish cohortUlrike Peters, Johan Askling, Gloria Gridley, et al.
Rheumatology (Oxford, England)|March 20, 2026
Incident rheumatoid arthritis and work loss: a nationwide sibling comparison studyHeather Miller, Gustaf Bruze, Kari Johansson, et al.
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid arthritis and malignant lymphomasEva Baecklund, Johan Askling, Richard Rosenquist, et al.
RMD Open|November 8, 2018
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide studyUlf Lindström, Tor Olofsson, Sara Wedrén, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by EyubogluHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
Annals of the Rheumatic Diseases|March 3, 2023
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort studyViking Huss, Hannah Bower, Karin Hellgren, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Pageof 35

Showing results (71-80 of 345) with videos related to

Sort By:
Pageof 35
RMD Open|December 23, 2022
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish studyLiselotte Tidblad, Helga Westerlind, Benedicte Delcoigne, et al.
Arthritis Research & Therapy|May 30, 2019
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practiceUlf Lindström, Tor Olofsson, Sara Wedrén, et al.
Arthritis Care & Research|March 17, 2025
Juvenile Idiopathic Arthritis, Earnings, and Work Loss: A Nationwide Matched Cohort StudyHeather Miller, Martin Neovius, Erik Sundberg, et al.
Archives of Internal Medicine|July 16, 2003
Causes of death in patients with celiac disease in a population-based Swedish cohortUlrike Peters, Johan Askling, Gloria Gridley, et al.
Rheumatology (Oxford, England)|March 20, 2026
Incident rheumatoid arthritis and work loss: a nationwide sibling comparison studyHeather Miller, Gustaf Bruze, Kari Johansson, et al.
Current Opinion in Rheumatology|April 23, 2004
Rheumatoid arthritis and malignant lymphomasEva Baecklund, Johan Askling, Richard Rosenquist, et al.
RMD Open|November 8, 2018
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide studyUlf Lindström, Tor Olofsson, Sara Wedrén, et al.
Annals of the Rheumatic Diseases|March 30, 2019
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by EyubogluHelga Westerlind, Marie Holmqvist, Lotta Ljung, et al.
Annals of the Rheumatic Diseases|March 3, 2023
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort studyViking Huss, Hannah Bower, Karin Hellgren, et al.
RMD Open|December 20, 2023
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide studyLiselotte Tidblad, Helga Westerlind, Bénédicte Delcoigne, et al.
Pageof 35